Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Ask an expert: How can deep learning be used to detect disease?

Ask an expert: How can deep learning be used to detect disease?

Stories Jun 6, 2019 4 minutes

Our expert explains how advances in software technology could change the face of pathology and other clinical practices.

Innovations in artificial intelligence and deep learning are pushing technology closer to being able to perform complex clinical skills, such as diagnosing cancers. Neuropathologist and Vancouver Coastal Health Research Institute scientist, Dr. Stephen Yip, is at the forefront of developments in this area. He explains how deep learning is being used now and its potential impact in the future.  

Q: What is deep learning? 
A:
Deep learning, also known as deep neural networks, is a subset of artificial intelligence (AI), which is the pursuit of simulating human intelligence using machine technology. Deep learning is a multi-layered learning system that, similar to the human brain, can be taught to perform certain functions with the help of training data. 

Q: How is it used in pathology?
A:
In pathology, we use deep learning to identify disease. We input hundreds, if not hundreds of thousands, of annotated images of diseased and healthy tissue samples into a deep neural network. This teaches its neurons—multiple information detection layers that are able to identify features such as shapes, sizes and colours in an image—how to differentiate between healthy and diseased cells. In a sense, deep learning and clinicians are trained in similar ways—through repetition, filtering information and exposure to many different data sets or images. 

Q: How is deep learning applied in clinical practices?
A:
Deep learning is currently being researched for use mostly in pathology—disease detection using tissue and bodily fluid samples—and radiology—the use of medical imaging to diagnose disease. This is because both of these diagnostic approaches are highly image-based. In terms of pathology, deep learning, and particularly convolutional neural networks (CNNs), is used to recognize unique features in images taken through microscopes. However, the success of this approach requires a large number of images—often thousands—that are annotated by clinicians to train the algorithm to recognize if part of an image contains, for example, cancerous or non-cancerous cells. 

Q: Is it safe for deep learning to be used to identify diseases like cancer? How do we know if the diagnosis is right? 
A:
Competitions between machines and clinicians have shown that deep learning can match or exceed the accuracy of seasoned experts when it comes to diagnosing diseases such as breast cancer, and in a shorter amount of time. However, this technology is still in the development stages. Deep learning continues to require a lot of human input to make a diagnosis, and it cannot yet replace the work of clinicians in Canada. 

Q: How advanced is this technology and what can we expect to see next?
A:
A lot of the recent advances have been made possible thanks to graphical processing units (GPUs), which are very well suited to the mathematical operations that are required in deep learning. There is now greater availability of large training sets because more clinicians are uploading and sharing annotated images online in the cloud. Another big advance is the availability of open source code for programming frameworks, which we use to develop industry-specific applications of deep learning, such as disease recognition in pathology.  

It used to take around 20-30 minutes to scan and digitize a slide containing a tissue sample, which is then stored and saved in the cloud and on computer servers. The newer generation scanners can accomplish this task in a few minutes and can manage batches of several slides at a time, greatly simplifying and fast tracking the process of digitizing slides. At this rate, the technology shows great promise for improving patient care in the future. We are already seeing signs that deep learning could quickly identify such things as genetic variants and offer long-term prognoses by making connections that would normally be undetected by the human eye. 

Q: What about my digital security?
A:
There is a natural tendency to be concerned about private information being uploaded to the cloud. However, in this case, there are robust security measures in place to protect patient confidentiality and privacy when working with deep learning. It would not receive approval from regulatory bodies governing privacy and health information in Canada if that was not the case. For example, all of our health data must be stored on Canadian servers and governed by Canadian laws.

Dr. Stephen Yip practices neuropathology at Vancouver General Hospital and is the director of the Cancer Genetics and Genomics Laboratory at BC Cancer. He is a certified neuropathologist trained in molecular neuro-oncology and molecular genetic pathology. His research interests include dissecting the molecular pathology of brain and spine cancers, practical deployment of advanced diagnostic assays and the application of deep learning as an integrative diagnostic tool. Yip co-authored “Rise of the machines: advances in deep learning for cancer diagnosis,” which was published in the journal Trends in Cancer in March 2019. 

 

Researchers

Stephen Yip

Related Articles

Behind the lab doors: Machine augmented care at the Robotics and Control Laboratory

Surgical Tattoos in Infrared to optimize robot-guided surgeries

Generating MRI images from ultrasounds scans

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Stories

Learning Health Systems strives to elevate patient-centred care

Jun 30, 2025 care delivery, knowledge translation, patient engagement
Type
Announcement

Innovation and Translational Research Awards 2025 Recipients

Jun 24, 2025 award
Type
Announcement

Decolonizing health research at the Indigenous Health Research Unit

Jun 20, 2025 people feature, indigenous health
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy